AstraZeneca is acquiring Alexion Pharmaceuticals for $39 billion, with the deal expected to close in the third quarter of 2021.
Johns Hopkins Scientists Discover Possible Key to Controlling Covid-19 Immune Response
Biological, Blood, Cells, Coronavirus Disease 2019 (COVID-19), Factor D Protein, Immune System, Inflammation, Johns Hopkins University School of Medicine, Membranes, R&D, Researchers, SARS-CoV-2 spike protein, Sugar MoleculesResearchers at Johns Hopkins Medicine identified a protein – known as factor D – that appears essential to the inflammatory process of SARS-CoV-2, the virus that causes Covid-19.